Canada markets closed

Navidea Biopharmaceuticals, Inc. (NAVB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0350-0.0010 (-2.78%)
At close: 03:47PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2022-12-31
2021-12-31
2020-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
1,996
4,231
2,670
Total Cash
1,996
4,231
2,670
Net Receivables
0.61
1.021
58.754
Inventory
427.344
151.155
169.798
Other Current Assets
780.11
908.273
700.716
Total Current Assets
3,204
5,383
6,528
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
943.088
1,315
1,304
Accumulated Depreciation
-787.441
-1,067
-921.402
Net property, plant and equipment
155.647
248.705
382.257
Intangible Assets
1,000
785.651
620.241
Other long-term assets
11.774
227.192
227.192
Total non-current assets
1,168
1,262
1,230
Total Assets
4,372
6,645
7,758
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
543.613
453.427
745.443
Accounts Payable
2,123
1,421
1,162
Accrued liabilities
5,667
1,914
1,726
Deferred revenues
800
40.825
-
Other Current Liabilities
1.621
0.04
31.634
Total Current Liabilities
9,942
5,300
4,715
Non-current liabilities
Long Term Debt
1,872
-
-
Deferred revenues
700
700
700
Total non-current liabilities
2,573
720.288
996.006
Total Liabilities
12,515
6,020
5,711
Stockholders' Equity
Common Stock
223.697
221.349
218.278
Retained Earnings
-388,003
-370,788
-359,057
Total stockholders' equity
-8,436
-106.556
1,316
Total liabilities and stockholders' equity
4,372
6,645
7,758